Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C‐infected persons: Results from <scp>ERCHIVES</scp>

Y. Chen, J.; Ren, Yanjie; Yan, P.; E. Belina, Morgan; T. Chung, Raymond; A. Butt, Adeel

doi:10.1111/jvh.12884

Public

Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C‐infected persons: Results from ERCHIVES

Published in Journal of Viral Hepatitis • Feb 25, 2018

Authors:

J. Y. Chen

Yanjie Ren

P. Yan

Abstract

Recent preclinical studies have suggested an antifibrotic role for tricyclic antidepressants (TCA). Using the Electronically Retrieved Cohort of hepatitis C virus (HCV) Infected Veterans, we aimed to evaluate the impact of TCA use on fibrosis progression and development of hepatocellular carcinoma (...

Subject

Medicine

Internal medicine

Cirrhosis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!